تداخل‌های دارویی
Dalfampridine + Linagliptin-metformin
شدت: متوسط
Dalfampridine and Linagliptin-metformin: moderate interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Both metformin and dalfampridine are eliminated partly by renal OCT2-mediated secretion, so they could compete and raise each other's concentrations. Higher dalfampridine exposure raises seizure risk, particularly in patients with reduced renal function.
معنای این تداخل به زبان ساده
Dalfampridine and Linagliptin-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Dalfampridine belongs to Central Nervous System; Linagliptin-metformin belongs to Endocrine.
چرا رخ می‌دهد
Competition at renal organic cation transporter 2 may reduce tubular secretion of both drugs.
اقدام لازم
Check renal function before and during co-therapy and monitor for dalfampridine toxicity such as seizures or metformin adverse effects. Avoid in patients with moderate or severe renal impairment.
از داروساز چه بپرسید
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Dalfampridine و Linagliptin-metformin، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Linagliptin-metformin
تداخلات دیگر Dalfampridine
پرسش‌های متداول
Can I take Dalfampridine with Linagliptin-metformin?
MediHelp rates the interaction as moderate. Dalfampridine and Linagliptin-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both metformin and dalfampridine are eliminated partly by renal OCT2-mediated secretion, so they could compete and raise each other's concentrations. Higher dalfampridine exposure raises seizure risk, particularly in patients with reduced renal function.
How serious is the interaction between Dalfampridine and Linagliptin-metformin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check renal function before and during co-therapy and monitor for dalfampridine toxicity such as seizures or metformin adverse effects. Avoid in patients with moderate or severe renal impairment.
What other medicines interact with Linagliptin-metformin?
MediHelp also lists interactions of Linagliptin-metformin with, for example, Apalutamide, Carbamazepine, Contrast media. The full list is on the Linagliptin-metformin page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
